Great strides have been made in our understanding of the pathophysiology of primary
aldosteronism syndrome since Conn's description of the clinical presentation of a patient …

Primary aldosteronism (PA) is the most common form of endocrine hypertension and is
characterized by inappropriately elevated aldosterone production via a renin-independent …

Background Results of several studies published since 1999 suggest that primary
hyperaldosteronism (also known as Conn's syndrome) affects more than 10% of people with …

Primary aldosteronism (PA) causes cardiovascular damage in excess to the blood pressure
elevation, but there are no prospective studies proving a worse long-term prognosis in …

Objectives: This study investigated the influence of baseline and worsening renal function
(WRF) on the efficacy of spironolactone in patients with severe heart failure (HF) …

Background and aim Considering the amount of novel knowledge generated in the last five
years, a team of experienced hypertensionlogists was assembled to furnish updated clinical …

Objective: Obstructive sleep apnea (OSA) and primary aldosteronism are common in
subjects with resistant hypertension; it is unknown, however, if the two disorders are causally …

In the 60 years that have passed since the discovery of the mineralocorticoid hormone
aldosterone, much has been learned about its synthesis (both adrenal and extra-adrenal) …

Context: Primary aldosteronism (PA) is associated with vascular end-organ damage.
Objective: Our objective was to evaluate differences regarding comorbidities between the …

Context In primary aldosteronism (PA), two subtypes are distinguished: aldosterone-
producing adenoma (APA) and bilateral adrenal hyperplasia (BAH). In general, these are …